AP

Clinical trials for AP explained in plain language.

Never miss a new study

Get alerted when new AP trials appear

Sign up with your email to follow new studies for AP, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New antibiotic duos battle Drug-Resistant kidney infections

Disease control Completed

This large, completed Phase 3 study tested whether two new combinations of antibiotics (cefepime/nacubactam and aztreonam/nacubactam) work as well as a standard antibiotic (imipenem/cilastatin) for treating serious urinary tract or kidney infections in adults. The main goal was t…

Matched conditions: AP

Phase: PHASE3 • Sponsor: Meiji Seika Pharma Co., Ltd. • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

AP

Get alerted when new AP trials appear

New antibiotic duos battle Drug-Resistant kidney infections